Gene: SNORD17
Official Full Name: small nucleolar RNA, C/D box 17provided by HGNC
Gene Summary: Predicted to be involved in RNA processing. Predicted to be located in nucleolus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00957 | SNORD17 Knockout cell line(Hep G2) | Human | SNORD17 | 1:2~1:4 | Negative | Online Inquiry |
SNORD17 Gene Knockout Cell Lines are genetically modified cell lines specifically designed to lack the expression of the SNORD17 gene, which is known for its role in the biogenesis of small nucleolar RNAs (snoRNAs) and is implicated in processes such as RNA methylation and gene regulation. By utilizing CRISPR/Cas9 technology, these cell lines enable precise manipulation of gene function, providing researchers with a powerful tool to investigate the biological consequences of SNORD17 depletion.
The primary function of SNORD17 Gene Knockout Cell Lines is to facilitate in-depth research into the cellular pathways and mechanisms influenced by SNORD17. Upon knockout of this gene, cells exhibit alterations in ribosomal RNA processing and modifications that can impact cellular homeostasis, growth, and differentiation. By studying these changes in a controlled environment, scientists can elucidate the gene's role in various physiological and pathological contexts, including cancer progression and neurological disorders.
The scientific importance of SNORD17 Knockout Cell Lines lies in their potential applications in both basic research and clinical settings. These models provide insights into RNA-centric diseases and contribute to the understanding of snoRNA function in health and disease. Researchers can employ these cell lines to develop therapeutic strategies targeting SNORD17-associated pathways, paving the way for novel interventions.
What sets SNORD17 Gene Knockout Cell Lines apart from alternative models is their specificity and the robust nature of gene editing employed, which reduces off-target effects and enhances the reliability of experimental outcomes. Furthermore, as these cell lines are rigorously validated, they offer reproducible and reliable results that accelerate the discovery process.
For researchers and clinicians focused on RNA biology and its implications in disease, the SNORD17 Gene Knockout Cell Lines represent a transformative resource that holds exceptional value. Their use can lead to breakthrough discoveries and foster advancements in therapeutic development.
Our company is dedicated to providing cutting-edge biological products backed by a team of experts in genetic engineering and molecular biology. By continually advancing our offerings, we aim to support the scientific community in achieving their research goals effectively and efficiently.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.